Active Studies

A Prospective Blood Sample Collection Study to Develop and Validate a Panel of Protein-based Biomarkers in Patients with Pulmonary Nodules

Principal Investigator: Michael McCormack, MD
Co-Investigator: Victoria Giffi, MD

Enrolling

A Prospective Blood Sample Collection to Evaluate a Panel of Protein-Based Biomarkers

Principal Investigator: Michael McCormack, MD
Co-Investigator: Victoria Giffi, MD

Enrolling

A Phase 3, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Larazotide for Relief of Persistent Symptoms in Patients with Celiac Disease on a Gluten Free Diet

Principal Investigator: Chintamaneni Choudari, MD

Enrolling

Diabetic Retinopathy Screening using Smartphone-Based Fundus Photography and Artificial Intelligence. A Proof of Concept Study in a Community Based Clinic

Principal Investigator: John Wroblewski, MD
Co-Investigator: Jay Berdia, MD

Enrolling

A Phase 3, Multicenter. Randomized, Double-Blind, Placebo-Controlled Induction and Maintenance Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects with Eosinophilic Esophagitis

Principal Investigator: Chintamaneni Choudari, MD

Enrolling

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing - Ascertaining Serial Cancer Patients to Enable New Diagnostic II (DETECT -ASCEND 2)

Principal Investigator: Michael McCormack, MD
Co-Investigator: Victoria Giffi, MD

Enrolling

STOP-CANCER: Strategic Targeting for Optimal Prevention of Cancer

Principal Investigator: Michael McCormack, MD
Co-Investigator: Victoria Giffi, MD

Enrolling

Correct-MRD II: Seconds Colorectal Cancer Clinical Validation Study to Predict Recurrence Using A Circulating Tumor DNA Assay To Detect Minimal Residual Disease

Principal Investigator: Michael McCormack, MD
Co-Investigator: Victoria Giffi, MD

Enrolling

A Phase 3, Multicenter, Multinational, Open-Label Extension Study to Evaluate the Long-Term Safety of CC-93538 in Adult and adolescent Subjects with Eosinophilic Esophagitis

Principal Investigator: Chintamaneni Choudari, MD

Enrolling

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 4 Study of the Efficacy and Safety of Patiromer for Oral Suspension in Combination with the Standard of Care Treatment in Emergency Department Patients with Hyperkalemia (PLATINUM)

Principal Investigator: James Williams, DO

Enrolling

Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients

Principal Investigator: Michael McCormack, MD